50 related articles for article (PubMed ID: 11698416)
1. Screening and Characterization of Allosteric Small Molecules Targeting Bruton's Tyrosine Kinase.
Kueffer LE; Lin DY; Amatya N; Serrenho J; Joseph RE; Courtney AH; Andreotti AH
Biochemistry; 2024 Jan; 63(1):94-106. PubMed ID: 38091504
[TBL] [Abstract][Full Text] [Related]
2. ANKRD54 preferentially selects Bruton's Tyrosine Kinase (BTK) from a Human Src-Homology 3 (SH3) domain library.
Gustafsson MO; Mohammad DK; Ylösmäki E; Choi H; Shrestha S; Wang Q; Nore BF; Saksela K; Smith CI
PLoS One; 2017; 12(4):e0174909. PubMed ID: 28369144
[TBL] [Abstract][Full Text] [Related]
3. Conformational heterogeneity of the BTK PHTH domain drives multiple regulatory states.
Lin DY; Kueffer LE; Juneja P; Wales TE; Engen JR; Andreotti AH
Elife; 2024 Jan; 12():. PubMed ID: 38189455
[TBL] [Abstract][Full Text] [Related]
4. A self-scaffolding model for G protein signaling.
Wang J; Golebiewska U; Scarlata S
J Mol Biol; 2009 Mar; 387(1):92-103. PubMed ID: 19361438
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for Gβγ-mediated activation of phosphoinositide 3-kinase γ.
Chen CL; Syahirah R; Ravala SK; Yen YC; Klose T; Deng Q; Tesmer JJG
Nat Struct Mol Biol; 2024 Apr; ():. PubMed ID: 38565696
[TBL] [Abstract][Full Text] [Related]
6. Chemical degradation of BTK/TEC as a novel approach to inhibit platelet function.
Trory JS; Munkacsi A; Śledź KM; Vautrinot J; Goudswaard LJ; Jackson ML; Heesom KJ; Moore SF; Poole AW; Nabet B; Aggarwal VK; Hers I
Blood Adv; 2023 May; 7(9):1692-1696. PubMed ID: 36342848
[TBL] [Abstract][Full Text] [Related]
7. BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies.
Alu A; Lei H; Han X; Wei Y; Wei X
J Hematol Oncol; 2022 Oct; 15(1):138. PubMed ID: 36183125
[TBL] [Abstract][Full Text] [Related]
8. Bruton's tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironment.
Good L; Benner B; Carson WE
Cancer Immunol Immunother; 2021 Sep; 70(9):2439-2451. PubMed ID: 33818636
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of Vibratory Urticaria-Associated Adhesion-GPCR, EMR2/ADGRE2, Triggers the NLRP3 Inflammasome Activation Signal in Human Monocytes.
I KY; Tseng WY; Wang WC; Gordon S; Ng KF; Lin HH
Front Immunol; 2020; 11():602016. PubMed ID: 33488598
[TBL] [Abstract][Full Text] [Related]
10. Role of Bruton's tyrosine kinase in B cells and malignancies.
Pal Singh S; Dammeijer F; Hendriks RW
Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
[TBL] [Abstract][Full Text] [Related]
11. Identification of dual mechanisms mediating 5-hydroxytryptamine receptor 1F-induced mitochondrial biogenesis.
Gibbs WS; Garrett SM; Beeson CC; Schnellmann RG
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F260-F268. PubMed ID: 29046298
[TBL] [Abstract][Full Text] [Related]
12. Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia.
Voltan R; Rimondi E; Melloni E; Rigolin GM; Casciano F; Arcidiacono MV; Celeghini C; Cuneo A; Zauli G; Secchiero P
Oncotarget; 2016 Oct; 7(43):70623-70638. PubMed ID: 27661115
[TBL] [Abstract][Full Text] [Related]
13. BTK inhibitors in chronic lymphocytic leukemia: a glimpse to the future.
Spaargaren M; de Rooij MF; Kater AP; Eldering E
Oncogene; 2015 May; 34(19):2426-36. PubMed ID: 24954503
[TBL] [Abstract][Full Text] [Related]
14. Single cell imaging of Bruton's tyrosine kinase using an irreversible inhibitor.
Turetsky A; Kim E; Kohler RH; Miller MA; Weissleder R
Sci Rep; 2014 Apr; 4():4782. PubMed ID: 24759210
[TBL] [Abstract][Full Text] [Related]
15. Targeting Bruton's tyrosine kinase in B cell malignancies.
Hendriks RW; Yuvaraj S; Kil LP
Nat Rev Cancer; 2014 Apr; 14(4):219-32. PubMed ID: 24658273
[TBL] [Abstract][Full Text] [Related]
16. Ligand-dependent autophosphorylation of the insulin receptor is positively regulated by Gi-proteins.
Kreuzer J; Nürnberg B; Krieger-Brauer HI
Biochem J; 2004 Jun; 380(Pt 3):831-6. PubMed ID: 15025562
[TBL] [Abstract][Full Text] [Related]
17. G Protein beta gamma subunits act on the catalytic domain to stimulate Bruton's agammaglobulinemia tyrosine kinase.
Lowry WE; Huang XY
J Biol Chem; 2002 Jan; 277(2):1488-92. PubMed ID: 11698416
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinase-dependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cells.
Várnai P; Rother KI; Balla T
J Biol Chem; 1999 Apr; 274(16):10983-9. PubMed ID: 10196179
[TBL] [Abstract][Full Text] [Related]
19. Role of the PHTH module in protein substrate recognition by Bruton's agammaglobulinemia tyrosine kinase.
Lowry WE; Huang J; Lei M; Rawlings D; Huang XY
J Biol Chem; 2001 Nov; 276(48):45276-81. PubMed ID: 11577078
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
